See every side of every news story
Get Started
SubscribeLogin
SAG Awards
Olaf Scholz
Israel-Hamas Conflict
Military
Ukraine War
Hamas
Wrestling
Donald Trump
Elon Musk
Basketball
US Politics
Pope Francis
Published • loading... • Updated

AngioDynamics initiates AMBITION BTK RCT and registry to advance treatment for CLTI - Interventional News

Summary by Interventional News
AngioDynamics today announced the initiation of AMBITION BTK, a randomised study of the Auryon atherectomy system in the treatment of below-the-knee (BTK) chronic limb-threatening ischaemia (CLTI). AMBITION BTK is a multicentre, randomised controlled trial (RCT) designed to evaluate the clinical outcomes of the Auryon atherectomy system in combination with standard balloon angioplasty compared to standard balloon angioplasty alone for the treatm…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Interventional NewsInterventional News

AngioDynamics initiates AMBITION BTK RCT and registry to advance treatment for CLTI - Interventional News

AngioDynamics today announced the initiation of AMBITION BTK, a randomised study of the Auryon atherectomy system in the treatment of below-the-knee (BTK) chronic limb-threatening ischaemia (CLTI). AMBITION BTK is a multicentre, randomised controlled trial (RCT) designed to evaluate the clinical outcomes of the Auryon atherectomy system in combination with standard balloon angioplasty compared to standard balloon angioplasty alone for the treatm…

Read Full Article
Endovascular TodayEndovascular Today

AngioDynamics Initiates AMBITION BTK Trial of Auryon System for CLI - Endovascular Today

January 30, 2025—AngioDynamics, Inc. announced the commencement of the AMBITION BTK multicenter randomized controlled trial (RCT), which will evaluate clinical outcomes of the company’s Auryon atherectomy system used in combination with standard balloon angioplasty versus standard balloon angioplasty alone to treat infrapopliteal lesions in patients with critical limb ischemia (CLI) below the knee (BTK). According to the company, the AMBITION BT…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endovascular Today broke the news in on Thursday, January 30, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Maryland

Maryland

News
For You
Search
BlindspotLocal